Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.262ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBUENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.351.5 (Beta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FZ.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.9.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBC.1.6.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.4.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FQ.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JB.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.17ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.3.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FZ.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DV.7.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.30.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.68ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CD.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.122.3 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AD.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.26.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.10.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XAY.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CY.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBTENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.12ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.33ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.29ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.28ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CL.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BM.1.1.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBMENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.34ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CB.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BR.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CL.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.2.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CH.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EF.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BR.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.1.2.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CP.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.160.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
XBB.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BE.4.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBQENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.6.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used